Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1 Expanded_access 1

Sponsor

Cancer Type

Conditions

Osteosarcoma 1 Neoplasms, Bone Tissue 1

Interventions

Specimen Handling 415 Magnetic Resonance Spectroscopy 332 pembrolizumab 261 Biopsy 227 Carboplatin 216 Cisplatin 179 Cyclophosphamide 174 Paclitaxel 148 Nivolumab 135 Gemcitabine 130 Radiotherapy 120 Dexamethasone 105 Bevacizumab 101 fludarabine 95 Radiation 94 Fluorouracil 93 Pemetrexed 88 Doxorubicin 88 Docetaxel 83 Rituximab 82 venetoclax 81 durvalumab 81 Oxaliplatin 81 Leucovorin 76 atezolizumab 68 Lenalidomide 66 Capecitabine 66 Prednisone 65 Etoposide 64 Vincristine 62

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × mifamurtide × 30 days × Clear all

NCT03643133 2026-05-19

SARCOME13

UNICANCER

Phase 2 Active not recruiting

Osteosarcoma, Neoplasms, Bone Tissue

Data powered by HemOnc (CC BY 4.0) Colophon ⚡